Loading...
Cryo-Cell International Inc (CCEL) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to support a buy decision. It is better to hold off until there are clearer signs of growth or positive sentiment.
The technical indicators show a bearish trend with moving averages (SMA_200 > SMA_20 > SMA_5). The RSI is neutral at 38.886, and the MACD is slightly positive but contracting, indicating no strong momentum. The stock is trading near its pivot level of 3.342, with support at 3.175 and resistance at 3.508.
The gross margin increased by 4.75% YoY, which is a positive sign of operational efficiency.
There are no recent news updates, no significant insider or hedge fund activity, and no recent congress trading data. The stock has a bearish technical setup.
In Q3 2025, the company's revenue dropped to $7,825,432 (-2.99% YoY), net income dropped to $749,408 (-28.74% YoY), and EPS fell to 0.09 (-30.77% YoY). However, gross margin improved to 74.61% (+4.75% YoY). Overall, financial performance is weak with declining profitability metrics.
No analyst rating or price target data is available for CCEL.